Is the treatment of acute otitis media (AOM) and acute bacterial sinusitis (ABS) the same for children, adults, and older adults?

Treatment of Acute Otitis Media and Acute Bacterial Sinusitis: Age-Based Differences

No, the treatment of acute otitis media (AOM) and acute bacterial sinusitis (ABS) is NOT the same across all age groups—there are critical differences in antibiotic choice strength of recommendation and treatment duration between children and adults.

Acute Bacterial Sinusitis (ABS)

Antibiotic Selection

The primary antibiotic choice differs in strength of recommendation between age groups:

• Children: Amoxicillin-clavulanate is strongly recommended over amoxicillin alone (strong recommendation, moderate-quality evidence) 1
• Adults: Amoxicillin-clavulanate is recommended over amoxicillin alone, but with a weaker recommendation (weak recommendation, low-quality evidence) 1

Both age groups should receive high-dose amoxicillin-clavulanate (2 g orally twice daily for adults or 90 mg/kg/day orally twice daily for children) 1.

Treatment Duration

This is where the most significant difference exists:

• Adults: 5-7 days for uncomplicated ABS (weak recommendation, low-moderate quality evidence) 1
• Children: 10-14 days is still recommended (weak recommendation, low-moderate quality evidence) 1

This represents a substantial difference—children require nearly double the treatment duration of adults.

Adjunctive Therapies

Some adjunctive treatments show age-specific recommendations:

• Intranasal saline irrigation: Recommended only for adults (weak recommendation, low-moderate quality evidence) 1—no specific recommendation for children in the guidelines
• Intranasal corticosteroids: Recommended as adjunct for both groups, particularly with allergic rhinitis history (weak recommendation, moderate quality evidence) 1
• Decongestants/antihistamines: NOT recommended for either age group (strong recommendation, low-moderate quality evidence) 1

Acute Otitis Media (AOM)

Antibiotic Selection

The evidence for AOM is less age-differentiated in formal guidelines, but important considerations exist:

• First-line treatment: Amoxicillin is generally considered first-line across age groups 2, 3
• Amoxicillin-clavulanate: May be more effective than macrolides and cephalosporins in children 2
• Adults: Recent data shows oral antibiotics prescribed in 46% of adult AOM cases, with amoxicillin predominating, though topical antibiotics are used in 21% of cases 4—a practice not typically seen in children

Treatment Duration

While specific guideline recommendations for AOM duration by age are not as clearly delineated in the provided evidence as they are for ABS, recent data reveals:

• Most children currently receive 10-day courses despite guidelines suggesting 5-7 days may be appropriate for children ≥2 years with uncomplicated AOM 5
• The evidence base for AOM treatment recommendations varies considerably across guidelines 6

Age-Specific Considerations

Children with AOM 2:

• Amoxicillin-clavulanate for 10 days showed better clinical cure rates than shorter courses of cephalosporins
• Topical analgesics may provide rapid pain relief (10-30 minutes)
• Systemic steroids show no significant benefit

Adults with AOM 4, 7:

• Seek care more quickly after symptom onset
• More likely to complain of ear pain, decreased hearing, and sore throat
• Have increased rates of poor outcomes at 2 months compared to children
• Recovery relates more to individual patient characteristics than antibiotic choice
• Neither type nor duration of antibiotic significantly affected outcomes in one study 7

Critical Clinical Pitfalls

1. Don't assume adult and pediatric ABS treatment is identical: The treatment duration difference (5-7 days vs. 10-14 days) is substantial and evidence-based

2. Strength of evidence varies by age: The recommendation for amoxicillin-clavulanate in children with ABS is strong, while in adults it's weak—this reflects different quality of supporting evidence

3. Avoid routine MRSA coverage: Despite S. aureus being a potential pathogen, routine coverage for MRSA is NOT recommended during initial empiric therapy for either age group 1

4. Don't prescribe decongestants or antihistamines: These are strongly recommended AGAINST for ABS in all age groups 1

5. Older adults: While not specifically addressed in the guidelines, older adults (≥64 years) have lower AOM incidence (2.7/1000 person-years) compared to younger adults 4, but treatment principles follow adult recommendations

Practical Algorithm

For ABS:

• If child: Amoxicillin-clavulanate high-dose × 10-14 days
• If adult: Amoxicillin-clavulanate high-dose × 5-7 days
• Both: Add intranasal corticosteroids if allergic rhinitis history
• Adults only: Consider intranasal saline irrigation

For AOM:

• First-line all ages: Amoxicillin (or amoxicillin-clavulanate)
• Duration: Trending toward shorter courses (5-7 days) for children ≥2 years, though 10-day courses remain common practice
• Adults: Treatment decisions should consider individual patient characteristics and history of recurrent disease

The evidence clearly demonstrates that while the pathogenesis of AOM and ABS may be similar across age groups 8, the treatment approach—particularly duration and strength of antibiotic recommendations—differs meaningfully between children and adults.